Blog Category

Financial

Biophytis publishes its key financial figures as at 30 June 2022, announces a restatement of the financial statements published as of December 31st, 2021 and provides an update on the operational milestones

,

/

1 November 2022

Biophytis announces receipt of Nasdaq Notice

,

/

26 October 2022

Biophytis announces the drawing of the second tranche of ORNANE under the 2021 Atlas Contract for €4 million

,

/

30 June 2022

Biophytis announces its audited financial results for the year ended December 31, 2021, and provides updates on key operational achievements as well as perspectives for 2022

,

/

7 April 2022

Biophytis announces the drawing of the last tranche of ORNANE under the 2020 Atlas Contract for €3 million

,

/

22 December 2021

Biophytis obtains a new 10M€ loan structure with Kreos Capital

,

/

22 November 2021

Biophytis publishes its interim financial report for the first half of 2021 and provides updates on key operational developments and financing transactions

, , ,

/

17 September 2021

Biophytis announces new convertible bond financing for up to €32 million with Atlas and drawing of 2 tranches under the 2020 Atlas Contract for €6 million

,

/

21 June 2021

Biophytis receives €980,000 DeepTech Funding from BPI France for the Development of Macuneos (BIO201) in Dry AMD

,

/

29 April 2021

Biophytis Reports 2020 Full Year Results

,

/

26 February 2021

Biophytis Announces Closing of ADS Offering on Nasdaq Capital Market

,

/

15 February 2021

Biophytis Announces Pricing of $20.1 Million U.S. Initial Public Offering of American Depositary Shares and Approval to List on Nasdaq Capital Market

,

/

10 February 2021